Mestastop Solutions have signed a memorandum of understanding with Syngene to provide its proprietary platform for metastasis discovery on a non-exclusive basis to Syngene clients, as per certain terms and
News
Jun 10, 2022
Oct 30, 2024
Oct 29, 2024
